Reply to Banda et al., "Interpretation of Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine". (2019)
Attributed to:
Centre for Drug Safety Science (CDSS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1128/aac.00593-19
PubMed Identifier: 31126921
Publication URI: http://europepmc.org/abstract/MED/31126921
Type: Journal Article/Review
Volume: 63
Parent Publication: Antimicrobial agents and chemotherapy
Issue: 6
ISSN: 0066-4804